USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
USANA Health Sciences, Inc.NYSE: USNA
Research & Development · Q1 FY2026 · quarter ended Apr 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 1.4 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 0 | -100.0% |
| FY2024 | 2024-12-28 | 11.57M | +1.1% |
| FY2023 | 2023-12-31 | 11.45M | -1.0% |
| FY2022 | 2022-12-31 | 11.56M | +4.1% |
| FY2021 | 2021-12-31 | 11.11M | — |
Research & Development vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for USNA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥635.95M CNY | -21.0% | -6.4% | 3.3% | |
| LTM Apr 2026 | $302K USD | -28.8% | +28.7% | 0.2% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | R$0 BRL | — | — | 0.0% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding USNA) | — | -24.9% | +11.1% | 0.0% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 998.6M | 921.01M | 854.5M | 925.26M |
| Cost of Revenue | 230.93M | 207.28M | 189.4M | 175.75M | 200.85M |
| Gross Profit | 955.53M | 791.32M | 731.62M | 678.75M | 724.41M |
| Gross Margin | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| Research & Development | 11.11M | 11.56M | 11.45M | 11.57M | 0 |
| Selling, General & Admin | 774.23M | 672.14M | 627.1M | 600.86M | 337.37M |
| Operating Expenses | 785.34M | 683.7M | 638.54M | 612.43M | 673.54M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 39.7M |
| EBITDA | 192.89M | 130.22M | 123.11M | 98.86M | 82.07M |
| EBITDA Margin | 16.3% | 13.0% | 13.4% | 11.6% | 8.9% |
| Operating Income | 170.19M | 107.61M | 93.07M | 66.32M | 50.86M |
| Operating Margin | 14.3% | 10.8% | 10.1% | 7.8% | 5.5% |
| Interest Income | 2.52M | 3.79M | 9.64M | 11.32M | 2.42M |
| Interest Expense | 57K | 192K | 262K | 281K | 842K |
| Other Income / Expenses | 450K | 1.01M | 9.38M | 10.03M | (9.34M) |
| Income Before Tax | 170.64M | 108.62M | 102.45M | 76.35M | 41.53M |
| Pre-Tax Margin | 14.4% | 10.9% | 11.1% | 8.9% | 4.5% |
| Income Tax Expense | 54.14M | 39.27M | 38.67M | 34.29M | 30.05M |
| Net Income | 116.51M | 69.35M | 63.79M | 42.03M | 10.76M |
| Net Margin | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (Basic) | 5.78 | 3.60 | 3.33 | 2.20 | 0.58 |
| EPS (Diluted) | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
| Weighted Avg Shares | 20.15M | 19.25M | 19.25M | 19.06M | 18.57M |
| Weighted Avg Shares (Diluted) | 20.34M | 19.31M | 19.35M | 19.16M | 18.57M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.